Richard A Larson Selected Research

Myeloid Leukemia (Leukemia, Myelocytic)

3/2018	Pepsi® or Coke®? Influence of acid on dasatinib absorption.
1/2018	WT1 peptide vaccine in Montanide in contrast to poly ICLC, is able to induce WT1-specific immune response with TCR clonal enrichment in myeloid leukemia.
1/2013	Allogeneic Hematopoietic Cell Transplantation for Therapy-Related Myeloid Leukemia following Orthotopic Cardiac Transplantation.
3/2010	Cytogenetic and genetic pathways in therapy-related acute myeloid leukemia.
5/2009	Genome-wide association study to identify novel loci associated with therapy-related myeloid leukemia susceptibility.
8/2008	Therapy-related myeloid leukemia.
6/2008	Phase I study of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde-thiosemicarbazone (3-AP) in combination with high dose cytarabine in patients with advanced myeloid leukemia.
3/2007	Is secondary leukemia an independent poor prognostic factor in acute myeloid leukemia?
1/2007	Etiology and management of therapy-related myeloid leukemia.
5/2005	Therapy-related myeloid leukaemia: a model for leukemogenesis in humans.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard A Larson Research Topics

Disease

95	Neoplasms (Cancer) 01/2022 - 05/2002
84	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 06/2022 - 04/2002
81	Leukemia 01/2019 - 03/2002
43	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2022 - 05/2002
30	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2021 - 03/2002
25	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2020 - 03/2002
20	Philadelphia Chromosome 11/2021 - 03/2003
20	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2021 - 07/2002
15	Chromosome Aberrations (Chromosome Abnormalities) 01/2022 - 04/2002
13	Myeloid Leukemia (Leukemia, Myelocytic) 03/2018 - 09/2002
11	Infections 10/2021 - 08/2006
10	Acute Promyelocytic Leukemia 01/2022 - 11/2010
8	Blast Crisis (Blast Phase) 05/2013 - 05/2002
7	Residual Neoplasm 01/2021 - 03/2003
7	Thrombocytopenia (Thrombopenia) 10/2019 - 03/2007
6	Fatigue 01/2021 - 09/2002
6	Hematologic Neoplasms (Hematological Malignancy) 01/2020 - 12/2004
4	Disease Progression 01/2021 - 03/2007
4	Febrile Neutropenia 01/2021 - 10/2007
4	Lymphoma (Lymphomas) 01/2021 - 04/2004
4	Diarrhea 01/2021 - 07/2009
4	Cytopenia 10/2018 - 05/2002
3	Anemia 10/2019 - 04/2008
3	Hemorrhage 03/2017 - 08/2006
3	Prolymphocytic Leukemia 05/2015 - 09/2002
3	Exanthema (Rash) 01/2014 - 04/2008
2	Pathologic Complete Response 12/2021 - 05/2005
2	B-Cell Leukemia (Leukemia, B Cell) 01/2021 - 12/2007
2	Hyperbilirubinemia 01/2021 - 10/2005
2	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2020 - 11/2008
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 12/2019 - 06/2007
2	Vomiting 01/2018 - 01/2014
2	Nausea 01/2018 - 01/2014
2	Breast Neoplasms (Breast Cancer) 01/2016 - 01/2016
2	Multiple Myeloma 11/2015 - 02/2006

Drug/Important Bio-Agent (IBA)

33	Imatinib Mesylate (Gleevec)FDA Link 07/2021 - 05/2002
23	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2020 - 01/2003
19	MicroRNAs (MicroRNA)IBA 01/2016 - 12/2007
17	Tyrosine Kinase InhibitorsIBA 11/2022 - 01/2009
17	fludarabineIBA 05/2015 - 07/2002
13	nilotinib FDA Link 07/2021 - 02/2008
10	Dasatinib (BMS 354825)FDA Link 11/2021 - 05/2007
8	Proteins (Proteins, Gene)FDA Link 01/2017 - 12/2002
7	Alemtuzumab (Campath)FDA Link 01/2020 - 01/2009
7	Biological ProductsIBA 12/2019 - 07/2003
7	Rituximab (Mabthera)FDA Link 12/2018 - 01/2003
7	Alkylating AgentsIBA 01/2011 - 06/2002
6	midostaurinIBA 01/2021 - 01/2017
6	Daunorubicin (Cerubidine)FDA LinkGeneric 07/2015 - 11/2004
6	Interferon-alpha (Interferon Alfa)IBA 12/2009 - 03/2003
5	fms-Like Tyrosine Kinase 3IBA 01/2022 - 01/2017
5	Pharmaceutical PreparationsIBA 11/2021 - 05/2002
5	Azacitidine (5 Azacytidine)FDA Link 01/2020 - 05/2002
5	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2019 - 12/2010
5	Phosphotransferases (Kinase)IBA 03/2018 - 10/2008
5	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 03/2002
5	bcr-abl Fusion ProteinsIBA 01/2011 - 12/2002
4	Arsenic Trioxide (Trisenox)FDA Link 01/2022 - 11/2010
4	blinatumomabIBA 01/2021 - 01/2016
4	Core Binding Factors (Core-Binding Factor)IBA 01/2020 - 08/2005
4	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2020 - 06/2010
4	Interleukin-2 (IL2)IBA 04/2014 - 09/2002
4	nelarabine (506U78)FDA Link 10/2012 - 09/2006
4	InterferonsIBA 11/2010 - 01/2003
4	valspodar (PSC 833)IBA 09/2010 - 08/2002
3	tipifarnib (R115777)IBA 12/2021 - 12/2004
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 05/2015
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2018 - 05/2008
3	romiplostim FDA Link 01/2017 - 01/2010
3	alvocidib (flavopiridol)IBA 05/2015 - 06/2005
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2015 - 03/2007
3	Gemtuzumab (Mylotarg)FDA Link 06/2013 - 10/2005
3	Clofarabine (Clolar)FDA Link 06/2012 - 12/2005
3	Monoclonal AntibodiesIBA 10/2009 - 03/2003
3	NucleosidesIBA 09/2006 - 12/2003
3	Etoposide (VP 16)FDA LinkGeneric 01/2005 - 05/2004
2	enasidenibIBA 06/2022 - 01/2020
2	gilteritinibIBA 01/2022 - 10/2019
2	TransferasesIBA 12/2021 - 12/2004
2	ibrutinibIBA 10/2021 - 12/2018
2	selinexorIBA 11/2020 - 01/2018
2	RNA (Ribonucleic Acid)IBA 01/2018 - 01/2017
2	AnthracyclinesIBA 01/2018 - 09/2012
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2017 - 10/2005
2	Alanine Transaminase (SGPT)IBA 01/2017 - 10/2005
2	Bortezomib (Velcade)FDA Link 11/2015 - 03/2013
2	Histone Deacetylase InhibitorsIBA 04/2015 - 11/2008
2	vatalanib (PTK787)IBA 11/2014 - 10/2013

Therapy/Procedure

92	Therapeutics 11/2022 - 03/2002
41	Drug Therapy (Chemotherapy) 01/2022 - 04/2002
11	Cell Transplantation 01/2022 - 01/2009
8	Stem Cell Transplantation 01/2020 - 07/2003
8	Radiotherapy 01/2013 - 04/2002
7	Hematopoietic Stem Cell Transplantation 11/2020 - 10/2005
5	Transplantation 12/2019 - 01/2005
4	Remission Induction 11/2020 - 03/2013
4	Consolidation Chemotherapy 01/2020 - 09/2002
4	Homologous Transplantation 01/2019 - 09/2007
3	Salvage Therapy 12/2019 - 08/2005
3	Induction Chemotherapy 01/2013 - 06/2004